Advertisement

Reactions Weekly

, Volume 1747, Issue 1, pp 7–7 | Cite as

Canagliflozin associated with lower extremity amputation

Clinical study
  • 24 Downloads

Reference

  1. Matthews DR, et al. Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS Program. Diabetologia : 12 Mar 2019. Available from: URL: http://doi.org/10.1007/s00125-019-4839-8

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations